Kalundborg, a small Danish town, is experiencing a modern-day gold rush due to the production of the weight loss drug Wegovy by Novo Nordisk. Despite significant investment and job creation, the town faces challenges such as low school performance, health issues among children, and a transient workforce. While some young residents express a desire to leave for larger cities, others are hopeful about future opportunities. The local economy is heavily reliant on the pharmaceutical sector, raising concerns about sustainability.